Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
58
MLAB Quote, Financials, Valuation and Earnings
Last price:
$77.26
Seasonality move
:
9.15%
Day range:
$75.55 - $80.31
52-week range:
$55.45 - $155.12
Dividend yield:
0.84%
P/E ratio:
--
P/S ratio:
1.71x
P/B ratio:
2.36x
Volume:
114.4K
Avg. volume:
151.3K
1-year change:
-38.93%
Market cap:
$421.8M
Revenue:
$241M
EPS (TTM):
-$0.32
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MLAB
Mesa Laboratories, Inc.
|
$60.7M | $1.56 | 0.63% | 148.96% | $88.50 |
|
CGNX
Cognex Corp.
|
$261.9M | $0.29 | 3.89% | 32.95% | $48.40 |
|
FCUV
Focus Universal, Inc.
|
-- | -- | -- | -- | -- |
|
KEYS
Keysight Technologies, Inc.
|
$1.4B | $1.83 | 18.6% | 105.4% | $214.92 |
|
QRVO
Qorvo, Inc.
|
$1B | $2.11 | 7.4% | 329.19% | $101.78 |
|
SOTK
Sono-Tek Corp.
|
$5.2M | $0.02 | 1.13% | 14.94% | $7.75 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MLAB
Mesa Laboratories, Inc.
|
$76.38 | $88.50 | $421.8M | -- | $0.16 | 0.84% | 1.71x |
|
CGNX
Cognex Corp.
|
$38.90 | $48.40 | $6.5B | 60.09x | $0.09 | 0.84% | 6.81x |
|
FCUV
Focus Universal, Inc.
|
$3.41 | -- | $28M | -- | $0.00 | 0% | 64.86x |
|
KEYS
Keysight Technologies, Inc.
|
$206.61 | $214.92 | $35.4B | 42.30x | $0.00 | 0% | 6.66x |
|
QRVO
Qorvo, Inc.
|
$89.36 | $101.78 | $8.3B | 38.59x | $0.00 | 0% | 2.30x |
|
SOTK
Sono-Tek Corp.
|
$3.93 | $7.75 | $61.7M | 40.98x | $0.00 | 0% | 3.00x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MLAB
Mesa Laboratories, Inc.
|
50.03% | -0.464 | 48.38% | 1.29x |
|
CGNX
Cognex Corp.
|
5.03% | 2.376 | 1.04% | 2.79x |
|
FCUV
Focus Universal, Inc.
|
10.5% | -0.207 | 0.09% | 1.05x |
|
KEYS
Keysight Technologies, Inc.
|
32.1% | 1.500 | 8.87% | 1.52x |
|
QRVO
Qorvo, Inc.
|
30.62% | 1.275 | 18.37% | 2.05x |
|
SOTK
Sono-Tek Corp.
|
-- | 0.871 | -- | 3.36x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MLAB
Mesa Laboratories, Inc.
|
$33M | $4.7M | -0.43% | -0.95% | 7.78% | $7.1M |
|
CGNX
Cognex Corp.
|
$187.3M | $57.8M | 6.96% | 7.32% | 20.86% | $86M |
|
FCUV
Focus Universal, Inc.
|
-$7.9K | -$1.2M | -245.73% | -254.53% | -4112.89% | -$1.1M |
|
KEYS
Keysight Technologies, Inc.
|
$869M | $212M | 10.95% | 15.91% | 14.94% | $187M |
|
QRVO
Qorvo, Inc.
|
$500.1M | $187.5M | 4.3% | 6.36% | 17.72% | $42.2M |
|
SOTK
Sono-Tek Corp.
|
$2.5M | $421.2K | 8.47% | 8.47% | 8.16% | -$237.3K |
Mesa Laboratories, Inc. vs. Competitors
-
Which has Higher Returns MLAB or CGNX?
Cognex Corp. has a net margin of 4.08% compared to Mesa Laboratories, Inc.'s net margin of 6.38%. Mesa Laboratories, Inc.'s return on equity of -0.95% beat Cognex Corp.'s return on equity of 7.32%.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.54.3% $0.45 $357.1M CGNXCognex Corp.67.64% $0.10 $1.6B -
What do Analysts Say About MLAB or CGNX?
Mesa Laboratories, Inc. has a consensus price target of $88.50, signalling upside risk potential of 24.38%. On the other hand Cognex Corp. has an analysts' consensus of $48.40 which suggests that it could grow by 24.42%. Given that Cognex Corp. has higher upside potential than Mesa Laboratories, Inc., analysts believe Cognex Corp. is more attractive than Mesa Laboratories, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 CGNXCognex Corp.9 6 1 -
Is MLAB or CGNX More Risky?
Mesa Laboratories, Inc. has a beta of 0.901, which suggesting that the stock is 9.911% less volatile than S&P 500. In comparison Cognex Corp. has a beta of 1.530, suggesting its more volatile than the S&P 500 by 52.973%.
-
Which is a Better Dividend Stock MLAB or CGNX?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.84%. Cognex Corp. offers a yield of 0.84% to investors and pays a quarterly dividend of $0.09 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Cognex Corp. pays out 49.59% of its earnings as a dividend. Cognex Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Mesa Laboratories, Inc.'s is not.
-
Which has Better Financial Ratios MLAB or CGNX?
Mesa Laboratories, Inc. quarterly revenues are $60.7M, which are smaller than Cognex Corp. quarterly revenues of $276.9M. Mesa Laboratories, Inc.'s net income of $2.5M is lower than Cognex Corp.'s net income of $17.7M. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is -- while Cognex Corp.'s PE ratio is 60.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 1.71x versus 6.81x for Cognex Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.1.71x -- $60.7M $2.5M CGNXCognex Corp.6.81x 60.09x $276.9M $17.7M
-
Which has Higher Returns MLAB or FCUV?
Focus Universal, Inc. has a net margin of 4.08% compared to Mesa Laboratories, Inc.'s net margin of -4064.11%. Mesa Laboratories, Inc.'s return on equity of -0.95% beat Focus Universal, Inc.'s return on equity of -254.53%.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.54.3% $0.45 $357.1M FCUVFocus Universal, Inc.-27.53% -$0.16 $195.3K -
What do Analysts Say About MLAB or FCUV?
Mesa Laboratories, Inc. has a consensus price target of $88.50, signalling upside risk potential of 24.38%. On the other hand Focus Universal, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Mesa Laboratories, Inc. has higher upside potential than Focus Universal, Inc., analysts believe Mesa Laboratories, Inc. is more attractive than Focus Universal, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 FCUVFocus Universal, Inc.0 0 0 -
Is MLAB or FCUV More Risky?
Mesa Laboratories, Inc. has a beta of 0.901, which suggesting that the stock is 9.911% less volatile than S&P 500. In comparison Focus Universal, Inc. has a beta of 0.283, suggesting its less volatile than the S&P 500 by 71.657%.
-
Which is a Better Dividend Stock MLAB or FCUV?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.84%. Focus Universal, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Focus Universal, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLAB or FCUV?
Mesa Laboratories, Inc. quarterly revenues are $60.7M, which are larger than Focus Universal, Inc. quarterly revenues of $28.7K. Mesa Laboratories, Inc.'s net income of $2.5M is higher than Focus Universal, Inc.'s net income of -$1.2M. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is -- while Focus Universal, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 1.71x versus 64.86x for Focus Universal, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.1.71x -- $60.7M $2.5M FCUVFocus Universal, Inc.64.86x -- $28.7K -$1.2M
-
Which has Higher Returns MLAB or KEYS?
Keysight Technologies, Inc. has a net margin of 4.08% compared to Mesa Laboratories, Inc.'s net margin of 17.76%. Mesa Laboratories, Inc.'s return on equity of -0.95% beat Keysight Technologies, Inc.'s return on equity of 15.91%.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.54.3% $0.45 $357.1M KEYSKeysight Technologies, Inc.61.24% $1.32 $8.7B -
What do Analysts Say About MLAB or KEYS?
Mesa Laboratories, Inc. has a consensus price target of $88.50, signalling upside risk potential of 24.38%. On the other hand Keysight Technologies, Inc. has an analysts' consensus of $214.92 which suggests that it could grow by 4.02%. Given that Mesa Laboratories, Inc. has higher upside potential than Keysight Technologies, Inc., analysts believe Mesa Laboratories, Inc. is more attractive than Keysight Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 KEYSKeysight Technologies, Inc.7 4 0 -
Is MLAB or KEYS More Risky?
Mesa Laboratories, Inc. has a beta of 0.901, which suggesting that the stock is 9.911% less volatile than S&P 500. In comparison Keysight Technologies, Inc. has a beta of 1.194, suggesting its more volatile than the S&P 500 by 19.432%.
-
Which is a Better Dividend Stock MLAB or KEYS?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.84%. Keysight Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Keysight Technologies, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLAB or KEYS?
Mesa Laboratories, Inc. quarterly revenues are $60.7M, which are smaller than Keysight Technologies, Inc. quarterly revenues of $1.4B. Mesa Laboratories, Inc.'s net income of $2.5M is lower than Keysight Technologies, Inc.'s net income of $252M. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is -- while Keysight Technologies, Inc.'s PE ratio is 42.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 1.71x versus 6.66x for Keysight Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.1.71x -- $60.7M $2.5M KEYSKeysight Technologies, Inc.6.66x 42.30x $1.4B $252M
-
Which has Higher Returns MLAB or QRVO?
Qorvo, Inc. has a net margin of 4.08% compared to Mesa Laboratories, Inc.'s net margin of 11.3%. Mesa Laboratories, Inc.'s return on equity of -0.95% beat Qorvo, Inc.'s return on equity of 6.36%.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.54.3% $0.45 $357.1M QRVOQorvo, Inc.47.25% $1.28 $5.1B -
What do Analysts Say About MLAB or QRVO?
Mesa Laboratories, Inc. has a consensus price target of $88.50, signalling upside risk potential of 24.38%. On the other hand Qorvo, Inc. has an analysts' consensus of $101.78 which suggests that it could grow by 13.9%. Given that Mesa Laboratories, Inc. has higher upside potential than Qorvo, Inc., analysts believe Mesa Laboratories, Inc. is more attractive than Qorvo, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 QRVOQorvo, Inc.3 19 0 -
Is MLAB or QRVO More Risky?
Mesa Laboratories, Inc. has a beta of 0.901, which suggesting that the stock is 9.911% less volatile than S&P 500. In comparison Qorvo, Inc. has a beta of 1.366, suggesting its more volatile than the S&P 500 by 36.562%.
-
Which is a Better Dividend Stock MLAB or QRVO?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.84%. Qorvo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Qorvo, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLAB or QRVO?
Mesa Laboratories, Inc. quarterly revenues are $60.7M, which are smaller than Qorvo, Inc. quarterly revenues of $1.1B. Mesa Laboratories, Inc.'s net income of $2.5M is lower than Qorvo, Inc.'s net income of $119.6M. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is -- while Qorvo, Inc.'s PE ratio is 38.59x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 1.71x versus 2.30x for Qorvo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.1.71x -- $60.7M $2.5M QRVOQorvo, Inc.2.30x 38.59x $1.1B $119.6M
-
Which has Higher Returns MLAB or SOTK?
Sono-Tek Corp. has a net margin of 4.08% compared to Mesa Laboratories, Inc.'s net margin of 8.21%. Mesa Laboratories, Inc.'s return on equity of -0.95% beat Sono-Tek Corp.'s return on equity of 8.47%.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.54.3% $0.45 $357.1M SOTKSono-Tek Corp.48.07% $0.03 $18.7M -
What do Analysts Say About MLAB or SOTK?
Mesa Laboratories, Inc. has a consensus price target of $88.50, signalling upside risk potential of 24.38%. On the other hand Sono-Tek Corp. has an analysts' consensus of $7.75 which suggests that it could grow by 97.2%. Given that Sono-Tek Corp. has higher upside potential than Mesa Laboratories, Inc., analysts believe Sono-Tek Corp. is more attractive than Mesa Laboratories, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 SOTKSono-Tek Corp.1 1 0 -
Is MLAB or SOTK More Risky?
Mesa Laboratories, Inc. has a beta of 0.901, which suggesting that the stock is 9.911% less volatile than S&P 500. In comparison Sono-Tek Corp. has a beta of -0.274, suggesting its less volatile than the S&P 500 by 127.432%.
-
Which is a Better Dividend Stock MLAB or SOTK?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.84%. Sono-Tek Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Sono-Tek Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLAB or SOTK?
Mesa Laboratories, Inc. quarterly revenues are $60.7M, which are larger than Sono-Tek Corp. quarterly revenues of $5.2M. Mesa Laboratories, Inc.'s net income of $2.5M is higher than Sono-Tek Corp.'s net income of $423.7K. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is -- while Sono-Tek Corp.'s PE ratio is 40.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 1.71x versus 3.00x for Sono-Tek Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.1.71x -- $60.7M $2.5M SOTKSono-Tek Corp.3.00x 40.98x $5.2M $423.7K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
38
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
